Cargando…
Management of psoriasis as a systemic disease: what is the evidence?
BACKGROUND: Psoriasis is a chronic, systemic immune‐mediated disease characterized by development of erythematous, indurated, scaly, pruritic and often painful skin plaques. Psoriasis pathogenesis is driven by proinflammatory cytokines and psoriasis is associated with increased risk for comorbiditie...
Autor principal: | Korman, N.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187293/ https://www.ncbi.nlm.nih.gov/pubmed/31225638 http://dx.doi.org/10.1111/bjd.18245 |
Ejemplares similares
-
Biologics in the management of psoriasis
por: Bahner, Jennifer D, et al.
Publicado: (2009) -
Management of psoriasis in pregnancy – a review of the evidence to date
por: Ferreira, Clara, et al.
Publicado: (2020) -
Clinical potential of brodalumab in the management of psoriasis: the evidence to date
por: Sandoval, Laura F, et al.
Publicado: (2015) -
The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis
por: Guillet, Carole, et al.
Publicado: (2022) -
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease)
por: Benezeder, Theresa, et al.
Publicado: (2019)